In this GEN webinar, Justin Byers and Daniel Lin-Arlow, PhD, examine how enzymatic DNA synthesis and DNA construct design mitigate antibody expression challenges. Register here.
In this joint webinar, EndoFold, Inc. and Ansa Biotechnologies share results from a proof-of-concept collaboration demonstrating a new path forward: ultra-rapid synthesis of full-length therapeutic constructs paired with next-generation, designable delivery vehicles.
Join us in this webinar case study to discover ways to progress and iterate scientific work that were previously unimaginable. Get an exciting look at innovative platforms, such as the Retained Endoplasmic Cleavable Secretion (RELEASE) platform developed by Stanford’s Gao Lab.
This webinar covers Ansa’s unique enzymatic approach to DNA synthesis, and how Ansa has been able to provide the Cress Lab at the Innovative Genomics Institute with access to their repetitive and complex DNA sequences that is further enabling their work in microbial engineering.